For the first time, the fully mechanical heart made by BiVACOR, which uses the same technology as high-speed rail lines, has been implanted inside a human being. The feat marks a major step in ...

The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.

The BiVACOR implant worked for 105 days while he awaited a human transplant. Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent every weekday. Search for: ...

BiVACOR's Total Artificial Heart has been implanted, offering hope for heart failure patients. Kurt “CyberGuy" Knutsson has more on the quantum leap in cardiac care technology.

BiVACOR’s founder, Australian bioengineer Daniel Timms, who invented the device following his father’s death from heart disease, said it was “exhilarating to see decades of work come to ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial Heart (TAH), as a potential bridge to transplant for the adult ...

The BiVACOR THA hooked up with the CTO Dianiel Timms in the background. (Credit: BiVACOR) Outside of the brain, the heart is probably the organ that you miss the most when it ceases to function ...

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, a clinical-stage medical device company, announced today, the successful completion of the first phase of the FDA Early Feasibility Study, with ...

The creation of such a device, today known as the Bivacor Total Artificial Heart, was once inconceivable to almost everyone—but not Bud Frazier. I spoke with Frazier at his office at THI, ...

The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.

BiVACOR’s founder, Australian bioengineer Daniel Timms, who invented the device following his father’s death from heart disease, said it was “exhilarating to see decades of work come to ...